BOGDAHN, ULRICH,AIGNER, LUDWIG,WACHS, FRANK PETER,WINNER, BEATE,WINKLER, JUERGEN
申请号：
CA2555463
公开号：
CA2555463C
申请日:
2005.02.09
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention relates to the use of oligonucleotides for thepreparation of a pharmaceutical compositionfor the prevention or treatment of a disease, wherein neurogenesis and/orneuroregeneration has a beneficial effect, in particular adisease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia,-Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies,Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS DementiaComplex, Vascular Dementia, ProgressiveSupranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy,Hallervorden Spatz Disease, Huntington's disease, Stroke,Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, MacularDegeneration, Glaucoma, Cochlea Degeneration, Depression,Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.
